drugset / Trial / NCT01977378
A Study of Sustained-Release Desvenlafaxine Hydrochloride for the Treatment of Major Depressive Disorder
RandomizedParallel-groupDouble-blindTreatment
Summary
A multicenter, 10-week study to evaluate the efficacy and safety of Sustained-Release Desvenlafaxine Hydrochloride versus Sustained-Release venlafaxine Hydrochloride in adult with major depressive disorder.
Timeline
- Start
- 2013-10
- Primary completion
- 2014-09
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Desvenlafaxine | Other / unclassified | 50 mg | — |
| Subject | Desvenlafaxine | Other / unclassified | 100 mg | — |
| Comparator | Venlafaxine | Small molecule | 75 mg | — |
| Comparator | Venlafaxine | Small molecule | 225 mg | — |